Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Biosecurity
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Medical countermeasures=== Medical countermeasures (MCMs) are products such as [[biologics]] and [[pharmaceutical drug]]s that can protect from or treat the effects of a chemical, biological, radiological, or nuclear (CBRN) attack or in the case of public health emergencies. MCMs can also be used for prevention and diagnosis of symptoms associated with CBRN attacks or threats.<ref name="fdamcm">{{cite web|title=What are Medical Countermeasures?|url=https://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/AboutMCMi/ucm431268.htm|archive-url=https://web.archive.org/web/20150220210054/http://www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/AboutMCMi/ucm431268.htm|url-status=dead|archive-date=20 February 2015|website=FDA: Emergency Preparedness and Response|publisher=Food and Drug Administration|access-date=15 June 2016}}</ref> In the US, the [[Food and Drug Administration]] (FDA) runs a program called the "FDA Medical Countermeasures Initiative" (MCMi), with programs funded by the [[US government|federal government]]. It helps support "partner" agencies and organisations prepare for public health emergencies that could require MCMs.<ref name="fdamcm" /><ref>{{cite news|title=Alliance for Biosecurity applauds subcommittee efforts to sustain medical countermeasure funding|url=https://homelandprepnews.com/biological-threats/bioterrorism/18984-alliance-biosecurity-applauds-subcommittee-efforts-sustain-medical-countermeasure-funding/|access-date=15 June 2016|work=Homeland Preparedness News|date=8 June 2016|location=Washington, D.C.}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)